Public Profile

Linnea SA

Linnea SA, headquartered in Switzerland (CH), is a prominent player in the global pharmaceutical and biotechnology industry. Founded in 2005, the company has established itself as a leader in the development of innovative drug delivery systems and advanced formulations. With a strong operational presence across Europe and North America, Linnea SA focuses on providing high-quality solutions for both prescription and over-the-counter medications. The company’s core offerings include customised drug delivery technologies and formulation services, which are distinguished by their precision and adaptability to various therapeutic areas. Linnea SA has achieved significant milestones, including partnerships with major pharmaceutical firms, enhancing its market position as a trusted provider of pharmaceutical solutions. With a commitment to quality and innovation, Linnea SA continues to shape the future of drug development and delivery.

DitchCarbon Score

How does Linnea SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Linnea SA's score of 26 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

33%

Let us know if this data was useful to you

Linnea SA's reported carbon emissions

Linnea SA, headquartered in Switzerland (CH), currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. In the absence of specific emissions data, it is important to note that Linnea SA has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of publicly available information suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. As the global focus on sustainability and carbon neutrality intensifies, it is crucial for companies like Linnea SA to establish clear climate commitments and reduction initiatives to align with industry standards and stakeholder expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Linnea SA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Linnea SA is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Linnea SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Indena S.p.A.

IT
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Eevia Health

FI
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers